Is a High HDL-Cholesterol Level Always Beneficial?

被引:64
作者
Franczyk, Beata [1 ]
Rysz, Jacek [1 ]
Lawinski, Janusz [2 ]
Rysz-Gorzynska, Magdalena [3 ]
Gluba-Brzozka, Anna [1 ]
机构
[1] Med Univ Lodz, Dept Nephrol Hypertens & Family Med, PL-90549 Lodz, Poland
[2] Rzeszow Univ, Med Coll, Inst Med Sci, Dept Urol, PL-35549 Rzeszow, Poland
[3] Med Univ Lodz, Dept Ophthalmol & Visual Rehabil, PL-90549 Lodz, Poland
关键词
high-density lipoprotein; high levels; dysfunctional HDL; cardiovascular risk; HIGH-DENSITY-LIPOPROTEIN; ESTER TRANSFER PROTEIN; CORONARY-ARTERY-DISEASE; APOLIPOPROTEIN-A-I; CAUSE-SPECIFIC MORTALITY; SCAVENGER RECEPTOR BI; CARDIOVASCULAR RISK; PLASMA LECITHIN; ATHEROSCLEROSIS; MUTATION;
D O I
10.3390/biomedicines9091083
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The specific interest concerning HDL cholesterol (HDL-C) is related to its ability to uptake and return surplus cholesterol from peripheral tissues back to the liver and, therefore, to its role in the prevention of cardiovascular diseases, such as atherosclerosis and myocardial infarction, but also transient ischemic attack and stroke. Previous epidemiological studies have indicated that HDL-C concentration is inversely associated with the risk of cardiovascular disease and that it can be used for risk prediction. Some genetic disorders are characterized by markedly elevated levels of HDL-C; however, they do not translate into diminished cardiovascular risk. The search of the potential causative relationship between HDL-C and adverse events has shifted the attention of researchers towards the composition and function of the HDL molecule/subfractions. HDL possesses various cardioprotective properties. However, currently, it appears that higher HDL-C is not necessarily protective against cardiovascular disease, but it can even be harmful in extremely high quantities.
引用
收藏
页数:18
相关论文
共 120 条
[1]  
Allard-Ratick M, 2018, EUR HEART J, V39, P3
[2]  
Allard-Ratick MarcP., 2019, US Cardiol Rev, V13, P49, DOI 10.15420/usc.2019.3.2
[3]   The HDL proteome in acute coronary syndromes shifts to an inflammatory profile [J].
Alwaili, Khalid ;
Bailey, Dana ;
Awan, Zuhier ;
Bailey, Swneke D. ;
Ruel, Isabelle ;
Hafiane, Anouar ;
Krimbou, Larbi ;
Laboissiere, Sylvie ;
Genest, Jacques .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2012, 1821 (03) :405-415
[4]   Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting [J].
Angeloni, Emiliano ;
Paneni, Francesco ;
Landmesser, Ulf ;
Benedetto, Umberto ;
Melina, Giovanni ;
Luescher, Thomas Felix ;
Volpe, Massimo ;
Sinatra, Riccardo ;
Cosentino, Francesco .
EUROPEAN HEART JOURNAL, 2013, 34 (46) :3557-3562
[5]   Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J].
Ansell, BJ ;
Navab, M ;
Hama, S ;
Kamranpour, N ;
Fonarow, G ;
Hough, G ;
Rahmani, S ;
Mottahedeh, R ;
Dave, R ;
Reddy, ST ;
Fogelman, AM .
CIRCULATION, 2003, 108 (22) :2751-2756
[6]  
Arai T, 1996, J LIPID RES, V37, P2145
[7]   HDL in atherosclerosis: actor or bystander? [J].
Asztalos, BF ;
Schaefer, EJ .
ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (01) :21-29
[8]   High-density lipoprotein subpopulations in pathologic conditions [J].
Asztalos, BF ;
Schaefer, EJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (7A) :12E-17E
[9]   Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease [J].
Asztalos, BF ;
Brousseau, ME ;
McNamara, JR ;
Horvath, KV ;
Roheim, PS ;
Schaefer, EJ .
ATHEROSCLEROSIS, 2001, 156 (01) :217-225
[10]   REGRESSION OF ATHEROSCLEROTIC LESIONS BY HIGH-DENSITY-LIPOPROTEIN PLASMA FRACTION IN THE CHOLESTEROL-FED RABBIT [J].
BADIMON, JJ ;
BADIMON, L ;
FUSTER, V .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1234-1241